Twist Bioscience Shares Gain 10% After Antibody Evaluation Service Announcement
Twist Bioscience announced a service to produce and quickly evaluate antibodies for AI drug discovery research. Shares rose 10% to $175.81 as of midday Wednesday.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.